536 Bevacizumab in cervical cancer – the experience of a comprehensive cancer center in northern Portugal | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Cervical cancer

536 Bevacizumab in cervical cancer – the experience of a comprehensive cancer center in northern Portugal

Free

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

	Abstract	Full	Pdf
Oct 2021	41	0	10
Nov 2021	52	0	15
Dec 2021	16	0	3
Jan 2022	42	0	7
Feb 2022	13	0	2
Mar 2022	12	0	4
Apr 2022	4	0	4
May 2022	13	0	7
Jun 2022	10	0	3
Jul 2022	18	0	3
Aug 2022	6	0	5
Sep 2022	18	0	5
Oct 2022	7	0	4
Nov 2022	15	0	1
Dec 2022	16	0	3
Jan 2023	19	0	4
Feb 2023	16	0	1
Mar 2023	7	0	0
Apr 2023	4	0	0
May 2023	2	0	0
Jun 2023	2	0	0
Jul 2023	4	0	4
Aug 2023	2	0	3
Sep 2023	2	0	3
Oct 2023	90	0	2
Nov 2023	8	0	3
Dec 2023	29	0	1
Jan 2024	26	0	1
Feb 2024	8	0	4
Mar 2024	9	0	3
Apr 2024	6	0	4
Total	517	0	109